[{"Assets_0_Q2_USD":601301000.0,"CommonStockSharesOutstanding_0_Q2_shares":47217675.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":48113000.0,"NetIncomeLoss_1_Q2_USD":47787000.0,"NetIncomeLoss_2_Q2_USD":48655000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":47107000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46925000.0,"StockholdersEquity_0_Q2_USD":387845000.0,"EarningsPerShareBasic_1_Q2_USD":1.01,"EarningsPerShareBasic_2_Q2_USD":1.04,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]